Document is current
Any future updates will be listed below
-
Authors
Truthmann, Julia https://orcid.org/0000-0002-2849-7608
Freyer Martins Pereira, Julia https://orcid.org/0000-0001-6119-0651
Richter, Adrian https://orcid.org/0000-0002-3372-2021
Schuster, Franziska
Witte, Amelie
Böhm, Susanne
Greser, Alexandra https://orcid.org/0000-0003-1191-0483
Kamin, Petra
Stracke, Sylvia
Dörr, Marcus
Bülow, Robin
Engeli, Stefan https://orcid.org/0000-0002-3087-971X
Gágyor, Ildikó https://orcid.org/0000-0002-7974-7603
Hummers, Eva
Chenot, Jean-François https://orcid.org/0000-0001-8877-2950
-
Funding
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01KG2022)
Universitätsmedizin Greifswald
- License Information
-
More Information
Article History
Received: 12 July 2023
Accepted: 20 September 2023
First Online: 5 October 2023
Declarations
:
: The trial has been approved by the Ethics Committee of the University Medical Center Greifswald, Germany (27 July 2022 and 11 November 2022, FFV 02/22a). Written informed consent to participate will be obtained from all participants.
: No identifying images will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding author on request.
: The authors declare no competing interests. Tiofarma produced the trial medication and had no influence on the study design, analysis and interpretation of data.
